Abstract
Aggressive fibromatosis harbours mutations resulting in β-catenin protein stabilization. Primary cell cultures demonstrate constitutive tcf activation in aggressive fibromatosis. Expression and co-immunoprecipitation studies suggest that β-catenin binds and activates tcf-3 in this tumour. This is the first demonstration of tcf-3 activation by β-catenin stabilization in a human neoplastic process. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Alman BA, Pajerski ME, Diaz-Cano S, Corboy K and Wolfe HJ (1997a) Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol 6: 98–101
Alman BA, Li C, Pajerski ME, Diaz-Cano S and Wolfe HJ (1997b) Increased β-catenin protein and somatic APC mutations in sporadic aggressive fibromatosis (desmoid tumors). Am J Pathol 151: 329–334
Barker N, Huls G, Korinek V and Clevers H (1999) Restricted high level expression of TCF-4 protein in intestinal and mammary gland epithelium. Am J Pathol 154: 29–35
Barker N, Morin PJ and Clevers H (2000) The Yin-Yang of TCF/β-catenin signaling. Adv Cancer Res 77: 1–24
Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R and Birchmeier W (1996) Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382: 638–642
Brannon M, Brown JD, Bates R, Kimelman D and Moon, (1999) XCtBP is a XTcf-3 co-repressor with roles throughout Xenopus development. Development 126: 3159–3170
Chan EF, Gat U, McNiff JM and Fuchs E (1999) A common human skin tumor is caused by activating mutations in β-catenin. Nat Genet 21: 410–413
He TC, Chan TA, Vogelstein B and Kinzler KW (1999) PPAR-δ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99: 335–345
Korinek V, Barker N, Morin PJ and van Wichen D (1997) Constitutive transcriptional activation by a β-catenin-Tcf complex in APC2/2colon carcinoma. Science 275: 1784–1787
Li C, Bapat B and Alman BA (1998) Adenomatous polyposis coli gene mutation alters proliferation through its β-catenin-regulatory function in aggressive fibromatosis (desmoid tumor). Am J Pathol 153: 709–714
Miller JR, Hocking AM, Brown JD and Moon RT (1999) Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways. Oncogene 18: 7860–7872
Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW (1997) Activation of β-catenin-TCF signaling in colon cancer by mutations in β-catenin or APC. Science 275: 1787–1790
Munemitsu S, Albert I, Rubinfeld B and Polakis P (1996) Deletion of an amino-terminal sequence beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein. Mol Cell Biol 16: 4088–4094
Poon R, Smits R, Li C, Jagmohan-Changur S, Kong M, Cheon S, Yu C, Fodde R and Alman B (2001) Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene 20: 451–460
Roose J and Clevers H (1999). TCF transcription factors: molecular switches in carcinogenesis, Biochim Biophys Acta 1424(2–3): M23–M37
Roose J, Huls G, van Beest M, Moerer P, van der Horn K, Goldschmeding R, Logtenberg T and Clevers H (1999) Synergy between tumor suppressor APC and the β-catenin-Tcf4 target Tcf1. Science 285: 1923–1926
Sagara N and Katoh M (2000) Mitomycin C resistance induced by TCF-3 overexpression in gastric cancer cell line MKN28 is associated with DT-diaphorase down-regulation. Cancer Res 60: 5959–5962
Tejpar S, Nollet F, Li C, Wunder JS, Michils G, dal Cin P, Van Cutsem E, Bapat B, van Roy F, Cassiman JJ and Alman BA (1999) Predominance of β-catenin mutations and β-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18: 6615–6620
Tetsu O and McCormick F (1999) β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422–426
Zhou P, Byrne C, Jacobs J and Fuchs E (1995) Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate. Genes Dev 9: 700–713
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Tejpar, S., Li, C., Yu, C. et al. Tcf-3 expression and β -catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour). Br J Cancer 85, 98–101 (2001). https://doi.org/10.1054/bjoc.2001.1857
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1857
Keywords
This article is cited by
-
A Metabolomics Pilot Study on Desmoid Tumors and Novel Drug Candidates
Scientific Reports (2018)
-
β-catenin and transforming growth factor β have distinct roles regulating fibroblast cell motility and the induction of collagen lattice contraction
BMC Cell Biology (2009)
-
Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse
BMC Genomics (2007)
-
An association between the 4G polymorphism in the PAI-1 promoter and the development of aggressive fibromatosis (desmoid tumor) in familial adenomatous polyposis patients
Familial Cancer (2007)
-
The enigma of desmoid tumors
Current Treatment Options in Oncology (2006)